Indian Immunologicals Limited

Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products.

[Indian Immunologicals Limited @indimmune_]

We are delighted to share that 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝗜𝗜𝗟) has been honored with the prestigious 𝗙𝗧𝗖𝗖𝗜 (𝗙𝗲𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗧𝗲𝗹𝗮𝗻𝗴𝗮𝗻𝗮 𝗖𝗵𝗮𝗺𝗯𝗲𝗿𝘀 𝗼𝗳 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗲 𝗮𝗻𝗱 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆) 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗔𝘄𝗮𝗿𝗱 𝟮𝟬𝟮𝟲 𝗳𝗼𝗿 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 – 𝗟𝗮𝗿𝗴𝗲 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲𝘀.

This recognition reflects our continued commitment to advancing innovative, affordable, and impactful healthcare solutions across both human and animal health. A key recent milestone has been the development of 𝗜𝗻𝗱𝗶𝗮’𝘀 𝗳𝗶𝗿𝘀𝘁 𝗮𝗻𝗱 𝗼𝗻𝗹𝘆 𝗶𝗻𝗱𝗶𝗴𝗲𝗻𝗼𝘂𝘀𝗹𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗲𝗱 𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗔 𝘃𝗮𝗰𝗰𝗶𝗻𝗲, contributing to the nation’s self-reliance in critical vaccines. 𝗛𝗮𝘃𝗶𝘀𝘂𝗿𝗲 by IIL is the only indigenous Hep A vaccine, currently available in India.

The award was received on behalf of the company by 𝗦𝗮𝗿𝘁𝗵𝗮𝗸 𝗩𝗮𝘀𝘂𝗱𝗲𝘃𝗮, 𝗦𝗿. 𝗩𝗶𝗰𝗲 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁; 𝗗𝗿. 𝗣𝗿𝗮𝗱𝗲𝗲𝗽 𝗚𝘂𝗽𝘁𝗮, 𝗩𝗶𝗰𝗲 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁; 𝗮𝗻𝗱 𝗔𝗷𝗮𝘆 𝗦𝗮𝗶𝗻𝗶, 𝗗𝗲𝗽𝘂𝘁𝘆 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗠𝗮𝗻𝗮𝗴𝗲𝗿, from the Hon’ble Minister for IT, Electronics & Communications, Industries & Commerce and Legislative Affairs, Government of Telangana, 𝗦𝗵𝗿𝗶 𝗗. 𝗦𝗿𝗶𝗱𝗵𝗮𝗿 𝗕𝗮𝗯𝘂.

This milestone is a testament to the relentless efforts of our teams, our strong culture of innovation, and the trust of our partners worldwide.
At IIL, we remain committed to shaping global healthcare through science-driven innovation and creating a meaningful impact.

#FTCCI #ExcellenceAwards #Innovation #Healthcare #Vaccines #IIL #OneHealth #Hyderabad #ProudMoment

[Indian Immunologicals Limited @indimmune_]

It was a “Feel Good” moment to donate Rs.40,00,000 as a part of Corporate Social Responsibility (CSR) to one of India’s premier research institutes, Indian Institute of Science (IISc) in Bengaluru today. The cheque was presented by our Managing Director Dr.K.Anand Kumar to the Director of this prestigious institute Professor Dr. Govindan Rangarajan in the presence of many scientists, including Prof Usha Vijayaraghavan, Dean of Biological Sciences, Prof Sundar Swaminarayan, Chair, Department of Nephrology, Prof KJ Vinoy, Chair, ODAA, Prof Siddharth Jhunjhunwala, Department of Bioengineering and Dr.Pradeep Gupta, Head of R&D at Indian Immunologicals ltd.

Our ability to balance beautifully between making money (Profits) and Social Good is having a profound impact of our business and the respectability earned as a result.

IIL and IISc have worked together on the development of vaccines and one such product Elovac B (recombinant hepatitis B vaccine) has significantly provided affordability to our Universal Immunisation Programme run by the Ministry of Health and Family Welfare, Government of India. What once was a Rs.1000 Hep B vaccine in the 90s sold by a multinational is now made available in India for Rs.10.

Other areas of collaboration were discussed between the two groups.

@iiscbangalore @NDDB_Coop

#IIL #NDDB #OneHealth #CSR

[Indian Immunologicals Limited @indimmune_]

Dr. Naresh Pal Gangwar, IAS, Secretary to Government of India, Department of Animal Husbandry Dairying and Fisheries visited Indian Immunologicals Limited in Gachibowli Hyderabad. Dr K Anand Kumar, Managing Director IIL took him on a tour of IIL’s world class vaccine facility and briefed about the work that IIL does and it’s achievement of being the single largest contributor to vaccine security of the nation and also offering affordable vaccines to more than 60 countries. Hon’ble Secretary Shri Gangwar was appreciative of the facility and it’s up keep.

Dr. Santhosh Ghadage, DMD, and many senior officials were present on the occasion.

@NDDB_Coop @Dept_of_AHD

#OneHealth #MakeInIndia #IIL #NDDB

[Indian Immunologicals Limited @indimmune_]

Across generations, one truth has remained constant: vaccines save lives.

They protect every age, every stage, every generation — and they safeguard animals that support livelihoods and share our world.

At Indian Immunologicals Limited, we believe in One Health — where protecting humans and animals together builds stronger, healthier communities.

For every child. Every family. Every future.

This World Immunization Week, let’s reaffirm a simple truth: for every generation, vaccines work.

#WorldImmunizationWeek #VaccinesWork #OneHealth #IndianImmunologicals #Immunization #PublicHealth #AnimalHealth #vaccines #VaccinationAwareness #PreventiveHealthcare #HealthyCommunities #GlobalHealth #StrongerTogether #HealthForAll #DiseasePrevention #FutureReady #LivestockHealth #CommunityWellbeing #ScienceForHealth #ProtectEveryGeneration

[Indian Immunologicals Limited @indimmune_]

Today was a momentous occasion as our company celebrated its highest turnover of Rs.1586 Cr for the year 2025-26. To grace the occasion we had with us a well respected Industry leader Shri G.V.Prasad, Co-Chairman and Managing Director of Dr.Reddy’s Laboratories Ltd (@drreddys). In the past decade IIL contributing significantly to One Health has achieved a CAGR of 16%.

Speaking on the occasion and addressing our senior employees our MD Dr.K.Anand Kumar said “Today I stand before you with immense pride and gratitude. Achievement of the company’s highest turnover in history is not just a milestone but a testament to your dedication, resilience and unwavering commitment to our mission. We are not just a business, our ability to balance profits with social good has earned us achieve cult status. Governments, healthcare practitioners, patients, farmers are placing more trust on us and we need to rise to the occasion through integrity, innovation and excellence. The success is a result of the long hours in the R&D lab, precision in the production floors, tireless efforts by our sales team and the seamless coordination between all functions. Let us also on this occasion renew our committnent to push the boundaries of science, offer availability and affordability, maintain the high standards of quality and indulge in responsible manufacturing."

Speaking on the occasion G.V.Prasad said “ IIL and DRL share many parallels and are driven by common purpose to significantly improve health. I compliment IIL for contributing in the area of One Health. The efficiency with which IIL operates and the frugal innovation adopted has significantly contributed to its bottom line. It is amazing that the company is able to provide life saving vaccines at very affordable prices. I congratulate the entire team at IIL for serving the nation and wish it continued success”.

Later both the leaders along with Dr. Santhosh Ghadage Deputy Managing Director cut a cake in the midst of thunderous claps by our employees. Subsequently the leaders participated in a Q&A session answering to intelligent questions posed by our staff.

@NDDB_Coop

#IIL #NDDB #OneHealth

[Indian Immunologicals Limited @indimmune_]

Our company was represented at the World Vaccine Congress in Washington, USA by Dr.K.Anand Kumar, MD, IIL and Sarthak Vasudeva, Sr.Vice President, International business. The event provided an opportunity to interact with many across the globe from Academia, Industry, Finance and Regulatory. IIL has collaboration with the leading academic institutions across the globe and also exports its products to over 60 countries earning valuable foreign exchange for our country.

Dr.K.Anand Kumar also participated in a panel “Translating Public R&D into Animal Health Innovation” moderated by Dr.Karyn Havas, National Program Leader for Animal Health at USDA. Other members of the panel were Dr.Alan Young, CTO Medgene, Dr.Paul Lawrence, Director, R&D at Bimeda, Dr.Perot, computational biologist at USDA and Dr.Elizabeth Rieder, Senior Research Scientist at USDA.

On the sidelines, Dr.Kumar also met Dr.Mahesh Kumar, Sr.Vice President, Zoetis, and presented a signed copy of his recently launched book “Road to Anand”.

@NDDB_Coop

#IIL #NDDB #OneHealth

[Indian Immunologicals Limited @indimmune_]

𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗹𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝘁 𝗜𝗜𝗟.

No longer are companies respected solely on the top line revenues or bottom line profits. Investors, regulators, customers, employees, prospective employees and the common public hold in high esteem a company for its responsible approach towards the environment, social and governance (ESG).

Just because we make life saving vaccines is no excuse to deplete our natural valuable resources in the name of manufacturing.

It is a remarkable day at IIL today, as we have adopted greener and more sustainable solutions, in the presence of 𝗗𝗿. 𝗞 𝗔𝗻𝗮𝗻𝗱 𝗞𝘂𝗺𝗮𝗿, 𝗠𝗮𝗻𝗮𝗴𝗶𝗻𝗴 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿, 𝗜𝗜𝗟.

𝗣𝗶𝗽𝗲𝗱 𝗡𝗮𝘁𝘂𝗿𝗮𝗹 𝗚𝗮𝘀 𝗳𝗼𝗿 𝗕𝗼𝗶𝗹𝗲𝗿𝘀 𝗮𝘁 𝗚𝗮𝗰𝗵𝗶𝗯𝗼𝘄𝗹𝗶:

The introduction of PNG as an alternative fuel to High Speed Diesel (HSD) marks a significant step toward our organization’s sustainability goals and alignment with Nationally Determined Contributions (NDC) for reducing greenhouse gas emissions. By transitioning from fossil fuels HSD to PNG, we aim to enhance fuel efficiency, reduce environmental impact and promote clean energy usage across our operations.

The adoption of PNG as boiler fuel is expected to reduce our carbon emissions by 2200 tCO2e/annum and annual cost savings of approximately 20–25% through cleaner combustion and lower emissions from Boiler.

Additionally, PNG eliminates the need for fuel storage and handling logistics, improving safety and operational efficiency.

𝗜𝗻𝘀𝘁𝗮𝗹𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗦𝗼𝗹𝗮𝗿 𝗣𝗼𝘄𝗲𝗿 𝗣𝗹𝗮𝗻𝘁 𝗮𝘁 𝗚𝗮𝗰𝗵𝗶𝗯𝗼𝘄𝗹𝗶:

We have installed a ground-mounted captive solar power plant at Gachibowli site marking a major step towards renewable energy adoption and sustainable practices.

The 999.6 kW solar PV system, built with 1680 bifacial modules (595 Wp) and integrated with Rapid Shutdown Protection System (RPS), enhances energy efficiency and ensures high safety standards.

This initiative generates approximately 1.4 million units annually, reduces grid dependency, and contributes to an estimated reduction in carbon emissions by ~1,000 tCO2e/annum.

Kudos to IIL’s ever strong Engineering team ably led by Magesh Kumar for the above initiatives.
@NDDB_Coop

#Sustainability #ESG #ResponsibleManufacturing #GreenInitiatives #SustainableFuture #ClimateAction #Decarbonization #NetZero #EnvironmentalResponsibility #CleanEnergy #RenewableEnergy #SolarEnergy #EnergyTransition #GreenEnergy #CarbonReduction #SustainableOperations #EnergyEfficiency

[Indian Immunologicals Limited @indimmune_]

ASPIRE-BioNEST Signs Strategic MoU with Indian Immunologicals Ltd. to Advance One Health Innovation.

ASPIRE-BioNEST, a premier life sciences incubation center at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

As part of this engagement, Dr.K.Anand Kumar visited ASPIRE-BioNEST and interacted with incubated startups, sharing insights on product development, regulatory pathways, and scale-up strategies, thereby providing startups with valuable industry perspective.

The MoU was signed and exchanged between Dr.K.Anand Kumar, Managing Director, Indian Immunologicals Ltd., and Prof. S. Rajagopal, Director, ASPIRE-BioNEST, in the presence of Dr. D. Yogeswara Rao, Director, ASPIRE; Prof. P. Reddanna, Former Director, ASPIRE; Dr. Anil Kondreddy, CEO, ASPIRE-BioNEST; Dr. Ramakrishna, CEO, ASPIRE-TBI; Mr. Prasad Sreeramakavacham, Vice President – Finance, Indian Immunologicals Ltd.; Dr. Pradeep Kumar, Head – R&D, Indian Immunologicals Ltd along with other officials from both organizations.

This partnership represents an important step towards strengthening India’s biotechnology innovation ecosystem, with a strong emphasis on integrated human, animal, and environmental health under the One Health framework.

Under the MoU, startups will benefit from IIL’s technical mentorship and domain expertise, along with access—on a mutually agreed basis—to advanced process development and analytical facilities, including capabilities relevant to viral and bacterial vaccine development. Opportunities to leverage IIL’s CDMO capabilities for scale-up and manufacturing readiness will also be explored.

Dr.K.Anand Kumar stated that Indian Immunologicals Ltd. will actively support startups at ASPIRE-BioNEST by extending its full spectrum of expertise across the product development lifecycle—from early-stage research and validation to scale-up, regulatory pathways, and commercialization.

@NDDB_Coop

#IIL #NDDB #OneHealth

[Indian Immunologicals Limited @indimmune_]

𝗠𝗲𝗲𝘁 𝗜𝗜𝗟 𝗮𝘁 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 (𝗪𝗮𝘀𝗵𝗶𝗻𝗴𝘁𝗼𝗻, 𝗨𝗦𝗔)

We’re excited to share that 𝗜𝗜𝗟 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗻𝗴 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝗪𝗮𝘀𝗵𝗶𝗻𝗴𝘁𝗼𝗻, 𝗨𝗦𝗔 𝗮𝘁 𝘁𝗵𝗲 𝗜𝗻𝗱𝗶𝗮 𝗣𝗮𝘃𝗶𝗹𝗹𝗶𝗼𝗻. — connecting with thriving vaccine industry key stakeholders.

Our Managing Director 𝗗𝗿 𝗔𝗻𝗮𝗻𝗱 𝗞𝘂𝗺𝗮𝗿 and Sr Vice President - International Business, 𝗦𝗮𝗿𝘁𝗵𝗮𝗸 𝗩𝗮𝘀𝘂𝗱𝗲𝘃𝗮 shall be representing the company at the event.

Our 𝗠𝗗, 𝗗𝗿 𝗔𝗻𝗮𝗻𝗱 𝗞𝘂𝗺𝗮𝗿 will be part of the panel discussion on “𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗣𝘂𝗯𝗹𝗶𝗰 𝗥&𝗗 𝗶𝗻𝘁𝗼 𝗔𝗻𝗶𝗺𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻.” 𝗼𝗻 𝟭𝘀𝘁 𝗔𝗽𝗿'𝟮𝟲.

If you’re attending WVC and exploring collaboration opportunities, we’d love to connect. Companies can reach out to IIL to:

𝗮) 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 & 𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴
Discuss 𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀 for 𝗰𝗼-𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 and 𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴 pathways.
𝗯) 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀
Leverage IIL’s 𝘀𝗰𝗮𝗹𝗲 𝗼𝗳 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, 𝗰𝗼𝘀𝘁 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀, 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝗮𝗻𝗱 𝘀𝘁𝗿𝗼𝗻𝗴 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲—especially where these strengths create a compelling case for your candidate’s manufacturing strategy.
𝗰) 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀
Explore partnerships for 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗜𝗜𝗟’𝘀 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗹𝘆 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 in relevant markets.

#WorldVaccineCongress #HumanHealth #AnimalHealth #Vaccines #Licensing #CDMO #Biomanufacturing

[Indian Immunologicals Limited @indimmune_]

Our MD, Dr. Anand Kumar hosted Shri. Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare (@MoHFW_INDIA), Government of India and Chairman, HLL Biotech Ltd at our Gachibowli manufacturing facility. Senior officials from both sides discussed about possible collaborative opportunities in the field of vaccine.

It is pertinent to note that IIL has been a trusted and one of the largest supplier of human vaccines to the Universal Immunization Programme (UIP) run by Government of India for many years. Pentavalent vaccine, Measles-Rubella vaccine, DTP vaccine, Recombinant Hepatitis B vaccine are some of the major vaccines supplied. We are fortunate to live in a country wherein our Government procures life saving vaccines and provides it to all citizens free of cost.

@NDDB_Coop

[Indian Immunologicals Limited @indimmune_]

Road to Anand: Reflections of a Contented Soul - written by Dr. K. Anand Kumar.

The book explores themes of resilience, leadership, purpose, and the pursuit of inner contentment, encouraging readers—especially young leaders—to view adversity as a catalyst for growth and meaningful success.

Chapter 26 of the book: Not longing for long hours

Click on the link to read the news article by Express Pharma: https://t.co/VlKQ7TUTOA

[Indian Immunologicals Limited @indimmune_]

It is with pride to let know that our Managing Director, Dr.K.Anand Kumar has been conferred with the Dr.Verghese Kurien Memorial Award and Citation by Pt.Deen Dayal Upadhayaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan, Mathura. The award was presented by Dr. Abhijit Mitra, Vice Chancellor of esteemed University in the presence of Deans of various institutions, staff and several hundred students from the disciplines of veterinary sciences, fishery sciences, biotechnology etc.

Dr. Kumar spoke about the Visionary leader Dr.Kurien who decades ago addressed the top three goals of the modern SDGs, No poverty, Zero hunger, Good health and Well being. All this through creation of many institutions of importance including the creation of IIL in 1982.

@NDDB_Coop

[Indian Immunologicals Limited @indimmune_]

Proud to share that Indian Immunologicals Ltd is exhibiting at World Vaccine Congress Washington 2026 on 30 March – 2 April.

This event brings together decision-makers, innovators, and solution providers shaping the future of vaccines.

Join us in Washington. Extra 25% off with code SBEXH25 + 20% early-bird discount until 6 March.

👉 Register now:

https://t.co/iDrxbLgseT

𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝘂𝘀 𝙎𝙖𝙧𝙩𝙝𝙖𝙠 𝙑𝙖𝙨𝙪𝙙𝙚𝙫𝙖 𝗼𝗿 𝘿𝙧.𝙆.𝘼𝙣𝙖𝙣𝙙 𝙆𝙪𝙢𝙖𝙧 𝘁𝗼 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀. 𝗪𝗲 𝗮𝗿𝗲 @ 𝘽𝙤𝙤𝙩𝙝: 323

#WVCDC #WorldVaccineCongress #OneHealth #IIL #IndianImmunologicals #ContractManufacturing #ContractDevelopment